$GEVO

Bowron Kimberly T sold $22K of GEVO

Bowron Kimberly T (Chief of Staff) sold 15,470 shares of Gevo, Inc. (GEVO) at $1.43 on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bowron Kimberly T
Published Jun 15, 2026, 9:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The only new information is the disclosed sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

This provides a transparency datapoint on insider activity, but it does not introduce new fundamentals or guidance.

03

What to watch

Traders may still watch for patterns (multiple insider sales in a short window) or whether other insiders/10b5-1 plans show contrasting activity.

Relevance 2/10Novelty 5/10Timing: SEC Form 4 filed 2026-06-15 for a 2026-06-12 insider sale

Background

The article is an SEC Form 4 insider transaction disclosure for Gevo, Inc. (GEVO).

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

SEC Form 4 shows Gevo chief of staff Bowron Kimberly T sold 15,470 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing provides transaction size, price, and 10b5-1 status, but no new operational, financial, or regulatory information about Gevo.

Market effects

Minimal; this is a single insider transaction with no disclosed sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations; traders may ignore it absent follow-on news.

Key entities

  • Gevo, Inc.

    Company whose insider transaction is disclosed on SEC Form 4.

  • Bowron Kimberly T

    Chief of Staff who sold 15,470 shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.